Clinical Trial Update: Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating repeat radiation, minocycline, and bevacizumab in patients with recurrent glioma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Minocycline (minocycline)

Snippet

Sponsor: University of Utah | Conditions: Recurrent Glioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-06